BioNxt Solutions Statistics
Total Valuation
FRA:BXT has a market cap or net worth of EUR 65.99 million. The enterprise value is 70.31 million.
Market Cap | 65.99M |
Enterprise Value | 70.31M |
Important Dates
The next estimated earnings date is Friday, November 28, 2025.
Earnings Date | Nov 28, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Current Share Class | 121.18M |
Shares Outstanding | n/a |
Shares Change (YoY) | +7.92% |
Shares Change (QoQ) | +0.61% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 113.67M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 4,878.77 |
PB Ratio | -12.57 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -18.65 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.06
Current Ratio | 0.06 |
Quick Ratio | 0.02 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -4.60 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -392.79% |
Return on Invested Capital (ROIC) | n/a |
Return on Capital Employed (ROCE) | 133.70% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | 0.03 |
Inventory Turnover | n/a |
Taxes
Income Tax | -56,059 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +262.76% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | +262.76% |
50-Day Moving Average | 0.55 |
200-Day Moving Average | 0.38 |
Relative Strength Index (RSI) | 53.82 |
Average Volume (20 Days) | 39,186 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, FRA:BXT had revenue of EUR 13,526 and -3.77 million in losses. Loss per share was -0.03.
Revenue | 13,526 |
Gross Profit | 13,526 |
Operating Income | -3.32M |
Pretax Income | -3.83M |
Net Income | -3.77M |
EBITDA | -3.29M |
EBIT | -3.32M |
Loss Per Share | -0.03 |
Balance Sheet
The company has 2,645 in cash and 4.41 million in debt, giving a net cash position of -4.41 million.
Cash & Cash Equivalents | 2,645 |
Total Debt | 4.41M |
Net Cash | -4.41M |
Net Cash Per Share | n/a |
Equity (Book Value) | -5.25M |
Book Value Per Share | -0.04 |
Working Capital | -2.69M |
Cash Flow
Operating Cash Flow | -2.12M |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | 100.00% |
Operating Margin | -24,515.77% |
Pretax Margin | -28,284.98% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
FRA:BXT does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -7.92% |
Shareholder Yield | -7.92% |
Earnings Yield | -5.71% |
FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
FRA:BXT has an Altman Z-Score of -188.93 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -188.93 |
Piotroski F-Score | 2 |